A Phase 3, Randomized, Open-Label, Combination Treatment Study of Amivantamab and Carboplatin-Pemetrexed Compared…
Phase 3, Randomized, Open-label, Controlled Trial of Cabozantinib (XL184) in Combination with Atezolizumab…
A phase III, multicenter, randomized, open-label study comparing Atezolizumab (anti-PD-L1 antibody) in combination…
Multicenter, randomized, open-label, phase 3 study comparing selpercatinib to physician’s choice of cabozantinib…
IRONMAN: International Registry for Men with Advanced Prostate Cancer Study Type Observational (non…
